This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2016
Title: Inventor Huma Jawed: Pioneering Anti-Epileptic Innovations in Karachi
Introduction
Huma Jawed, based in Karachi, PK, is an innovative inventor recognized for her significant contributions to the field of neuroscience. Her research focuses on developing novel compounds aimed at enhancing treatment options for epilepsy, a condition affecting millions worldwide.
Latest Patents
Huma holds a notable patent titled "Modulation of c-FOS and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel anti-epileptic compound HHL-6." This invention explores the anti-epileptogenic effects of the tryptamine derivative HHL-6, analyzing its influence on the expression of key proteins BDNF and c-Fos. The results from her research indicate that HHL-6 possesses potent anticonvulsant and anti-epileptic properties, particularly in chemically induced epilepsy models. Her findings suggest that HHL-6 may inhibit epileptogenesis by modulating cellular and molecular factors contributing to the changes in the central nervous system associated with epilepsy.
Career Highlights
Throughout her career, Huma Jawed has dedicated herself to the investigation of new therapeutic avenues for epilepsy. Her unique approach combines innovative chemical compounds with a deep understanding of neurological processes, which has led to noteworthy advancements in the field.
Collaborations
Huma collaborates with a talented team, including colleagues Shabana Usman Simjee and Sabira Begum. These collaborations foster an environment of teamwork and shared knowledge, propelling research initiatives forward and enhancing the overall impact of their scientific endeavors.
Conclusion
Huma Jawed is a distinguished inventor whose work on the anti-epileptic compound HHL-6 is paving the way for new treatments that could significantly improve the quality of life for individuals suffering from epilepsy. Her innovative spirit, combined with dedicated teamwork and research, exemplifies the progress being made in the fight against neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile